MARKET

XAIR

XAIR

Beyond Air Inc
NASDAQ
1.280
+0.190
+17.43%
Closed 19:55 12/04 EST
OPEN
1.100
PREV CLOSE
1.090
HIGH
1.300
LOW
1.100
VOLUME
145.08K
TURNOVER
79.66K
52 WEEK HIGH
11.20
52 WEEK LOW
1.000
MARKET CAP
10.25M
P/E (TTM)
-0.1699
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at XAIR last week (1124-1128)?
Weekly Report · 4d ago
Beyond Air CFO Doug Larson Announces Resignation
TipRanks · 6d ago
Beyond Air CFO Doug Larson Resigns, Controller Duke Drewell Named Interim Successor
Reuters · 6d ago
Chagee Holdings, Tilray Brands And 3 Stocks To Watch Heading Into Friday
Benzinga · 11/28 05:57
Beyond Air CFO Larson Resigns; Drewell Named Interim CFO
Dow Jones · 11/26 21:46
*Beyond Air: Larson Will Serve in Advisory Role Through End of Yr to Support Smooth Transition >XAIR
Dow Jones · 11/26 21:36
Beyond Air announces resignation of CFO Doug Larson
TipRanks · 11/26 21:35
*Beyond Air: Doug Larson Resigned as CFO to Pursue Another Opportunity >XAIR
Dow Jones · 11/26 21:35
More
About XAIR
Beyond Air, Inc. is a commercial-stage medical device and biopharmaceutical company dedicated to harnessing the power of endogenous and exogenous nitric oxide (NO) to improve the lives of patients suffering from respiratory illnesses, neurological disorders, and solid tumors. Its segments include Beyond Air, Beyond Cancer, and NeuroNos. It has received United States Food and Drug Administration approval for its first system, LungFit PH, for the treatment of term and near-term neonates with hypoxic respiratory failure. The Company is advancing its other LungFit systems in clinical trials for the treatment of severe lung infections such as viral community-acquired pneumonia (including COVID-19) and nontuberculous mycobacteria. It has also partnered with The Hebrew University of Jerusalem to advance a pre-clinical program dedicated to the treatment of autism spectrum disorder and other neurological disorders. Its product pipeline includes LungFit PH, LungFit PRO, LungFit GO, and others.

Webull offers Beyond Air Inc stock information, including NASDAQ: XAIR real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, XAIR stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading XAIR stock methods without spending real money on the virtual paper trading platform.